Cost-effectiveness analysis of QuantiFERON®-TB 2nd Generation used for detection of tuberculosis infection in contact investigations

Kekkaku

Volumn 80, Issue 11, 2005, Pages 675-686

  Mori, Toru ^a   Harada, Nobuyuki ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Contact investigation; Cost effectiveness analysis; QuantiFERON; Tuberculin reaction; Tuberculosis infection

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULOSTATIC AGENT;

ARTICLE; BCG VACCINATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; TUBERCULIN TEST; TUBERCULOSIS;

CONTACT TRACING; COST-BENEFIT ANALYSIS; HUMANS; INTERFERON TYPE II; JAPAN; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 28844437880     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)